Lead-In Parenteral Anticoagulation Prior to Direct Oral Anticoagulation for Cerebral Venous Thrombosis
In this cohort of patients receiving DOAC for CVT as part of routine care, >75% had <5 days of PA. Those with very early/early initiation of DOAC had less severe clinical presentations. Low event rates and baseline differences between groups preclude conclusions about safety or effectiveness. Further prospective data will inform care.
Authors
- Lily Zhou (ORCID: https://orcid.org/0000-0002-3064-0864)
- Shadi R. Yaghi (ORCID: https://orcid.org/0000-0003-0031-1004)
- Mary Cushman (ORCID: https://orcid.org/0000-0002-7871-6143)
- Liqi Shu (ORCID: https://orcid.org/0000-0002-9784-8475)
- James Ernest Siegler (ORCID: https://orcid.org/0000-0003-0287-3967)
- Thanh N. Nguyen (ORCID: https://orcid.org/0000-0002-2810-1685)
- Thalia Shoshana Field (ORCID: https://orcid.org/0000-0002-1176-0633)
- Piers Klein (ORCID: https://orcid.org/0000-0001-7468-137X)
- Diana Kim (ORCID: https://orcid.org/0000-0002-0243-799X)
Institutions
- University of Vermont (US)
- Boston Medical Center (US)
- University of British Columbia (CA)
- Brown University (US)
- University of Chicago (US)
- Okanagan University College (CA)
Publication Details
- Journal
- Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1017/cjn.2024.325
- Citations
- 2
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74